Heart Beat: January 2021

New Drug Shows Significant Benefit in Heart Failure Most patients with heart failure with reduced ejection fraction (HFrEF) take multiple medications to help their heart pump more forcefully and slow the inevitable decline in their condition. In clinical trials, a novel drug called vericiguat has been shown to provide additional benefit to HFrEF patients already […]
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access